亞培
ABT106.090USD
+0.040+0.04%
收盤 01/29, 16:00（美東）報價延遲15分鐘
184.48B總市值
28.44本益比TTM
關於 亞培 公司
亞培是一家橫跨全球的醫療保健領導者，專注於多元健康產品的研發、製造與銷售，業務框架涵蓋四大單元：成熟藥品、診斷、營養以及醫療器械。成熟藥品單元負責多品牌仿製藥的國際行銷；診斷單元向血庫、醫院、商業實驗室與替代護理點提供檢測系統與試劑；營養單元經營成人及兒童營養品全球通路；醫療器械單元銷售節律管理、電生理、心衰、血管、結構心臟、神經調控及糖尿病護理裝置，持續推動創新改善患者生命品質。其全球供應鏈覆蓋六大洲，利用數據分析與可持續製造提升效率與品質保障。
亞培簡介
公司代碼ABT
公司名稱Abbott Laboratories
上市日期Apr 06, 2073
CEOFord (Robert B)
員工數量114000
證券類型Ordinary Share
年結日Apr 06
公司地址100 Abbott Park Road
城市ABBOTT PARK
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編60064-3500
電話12246676100
網址https://www.abbott.com
公司代碼ABT
上市日期Apr 06, 2073
CEOFord (Robert B)
亞培公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+1635.00%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
132.23K
-1536.00%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-791.00%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.61K
-269.00%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
50.97K
-387.00%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
+1635.00%
Ms. Sally E. Blount, Ph.D.
Ms. Sally E. Blount, Ph.D.
Independent Director
Independent Director
34.06K
-965.00%
Mr. John G. Stratton
Mr. John G. Stratton
Independent Director
Independent Director
19.03K
+1635.00%
Ms. Michelle A. Kumbier
Ms. Michelle A. Kumbier
Independent Director
Independent Director
15.71K
+1635.00%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+1635.00%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
132.23K
-1536.00%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-791.00%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.61K
-269.00%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
50.97K
-387.00%
收入明細
單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Diabetes Care
2.06B
18.09%
Core Laboratory
1.36B
12.00%
Structural Heart
1.28B
11.23%
Adult Nutritionals
1.18B
10.34%
Key Emerging Markets
1.10B
9.65%
其他
4.40B
38.68%
地區USD
名稱
營收
佔比
All other Countries
7.07B
62.19%
United States
4.30B
37.81%
業務
地區
業務USD
名稱
營收
佔比
Diabetes Care
2.06B
18.09%
Core Laboratory
1.36B
12.00%
Structural Heart
1.28B
11.23%
Adult Nutritionals
1.18B
10.34%
Key Emerging Markets
1.10B
9.65%
其他
4.40B
38.68%
股東統計
更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
10.05%
BlackRock Institutional Trust Company, N.A.
5.13%
State Street Investment Management (US)
4.50%
Capital International Investors
3.54%
Capital Research Global Investors
2.23%
其他
74.55%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
10.05%
BlackRock Institutional Trust Company, N.A.
5.13%
State Street Investment Management (US)
4.50%
Capital International Investors
3.54%
Capital Research Global Investors
2.23%
其他
74.55%
股東類型
持股股東
佔比
Investment Advisor
47.26%
Investment Advisor/Hedge Fund
23.11%
Research Firm
3.51%
Pension Fund
2.34%
Bank and Trust
2.20%
Sovereign Wealth Fund
1.37%
Insurance Company
1.02%
Hedge Fund
0.49%
Individual Investor
0.48%
其他
18.22%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
4606
1.42B
81.82%
+3.92M
2025Q3
4681
1.42B
81.87%
+8.53M
2025Q2
4668
1.41B
81.51%
+6.23M
2025Q1
4636
1.40B
80.10%
+7.18M
2024Q4
4554
1.38B
78.81%
+33.68M
2024Q3
4367
1.35B
78.83%
-5.95M
2024Q2
4376
1.35B
78.36%
+5.03M
2024Q1
4375
1.35B
77.56%
-1.86M
2023Q4
4400
1.34B
77.62%
+7.10M
2023Q3
4258
1.33B
78.26%
-4.16M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
174.89M
10.06%
+2.54M
+1.47%
Nov 28, 2025
BlackRock Institutional Trust Company, N.A.
89.23M
5.13%
+711.43K
+0.80%
Sep 30, 2025
State Street Investment Management (US)
78.23M
4.5%
-128.28K
-0.16%
Sep 30, 2025
Capital International Investors
61.61M
3.54%
+1.48M
+2.46%
Sep 30, 2025
Capital Research Global Investors
38.77M
2.23%
-3.00M
-7.18%
Sep 30, 2025
Geode Capital Management, L.L.C.
38.54M
2.22%
+248.83K
+0.65%
Sep 30, 2025
Wellington Management Company, LLP
23.25M
1.34%
-1.80M
-7.20%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
22.25M
1.28%
+1.27M
+6.03%
Jun 30, 2025
JP Morgan Asset Management
19.25M
1.11%
-7.14M
-27.05%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
17.77M
1.02%
+9.40M
+112.38%
Sep 30, 2025
查看更多
持股ETF
更新時間: 11月5日 週三
更新時間: 11月5日 週三
機構名稱
佔比
iShares U.S. Medical Devices ETF
19.31%
Goldman Sachs Future Health Care Equity ETF
6.26%
SMI 3Fourteen Full-Cycle Trend ETF
5.01%
Invesco Pharmaceuticals ETF
4.99%
Health Care Select Sector SPDR Fund
4.62%
Proshares Ultra Health Care
4.61%
Tema Heart & Health ETF
4.5%
iShares U.S. Healthcare ETF
4.42%
AdvisorShares Focused Equity ETF
4.37%
Polen Capital Global Growth ETF
4.27%
查看更多
iShares U.S. Medical Devices ETF
佔比19.31%
Goldman Sachs Future Health Care Equity ETF
佔比6.26%
SMI 3Fourteen Full-Cycle Trend ETF
佔比5.01%
Invesco Pharmaceuticals ETF
佔比4.99%
Health Care Select Sector SPDR Fund
佔比4.62%
Proshares Ultra Health Care
佔比4.61%
Tema Heart & Health ETF
佔比4.5%
iShares U.S. Healthcare ETF
佔比4.42%
AdvisorShares Focused Equity ETF
佔比4.37%
Polen Capital Global Growth ETF
佔比4.27%
分紅派息
近5年累計派現
13.90B
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Dec 12, 2025
ABT.NB Final Cash Dividend of gross USD 0.63 paid on Feb 13, 2026 going ex on Jan 15, 2026 with reinvestment option
Jan 15, 2026
Feb 13, 2026
Jan 15, 2026
Sep 19, 2025
ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Nov 17, 2025 going ex on Oct 15, 2025 with reinvestment option
Oct 15, 2025
Nov 17, 2025
Oct 15, 2025
Jun 13, 2025
ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Aug 15, 2025 going ex on Jul 15, 2025 with reinvestment option
Jul 15, 2025
Aug 15, 2025
Jul 15, 2025
Feb 21, 2025
ABT.NB Interim Cash Dividend of gross USD 0.59 paid on May 15, 2025 going ex on Apr 15, 2025 with reinvestment option
Apr 15, 2025
May 15, 2025
Apr 15, 2025
Dec 13, 2024
ABT.NB Final Cash Dividend of gross USD 0.59 paid on Feb 14, 2025 going ex on Jan 15, 2025 with reinvestment option
Jan 15, 2025
Feb 14, 2025
Jan 15, 2025
Sep 19, 2024
ABT.NB Final Cash Dividend of gross USD 0.55 paid on Nov 15, 2024 going ex on Oct 15, 2024
Oct 15, 2024
Nov 15, 2024
Oct 15, 2024
Jun 15, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Aug 15, 2024 going ex on Jul 15, 2024 with reinvestment option
Jul 15, 2024
Aug 15, 2024
Jul 15, 2024
Feb 16, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on May 15, 2024 going ex on Apr 12, 2024
Apr 15, 2024
May 15, 2024
Apr 12, 2024
Dec 15, 2023
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Feb 15, 2024 going ex on Jan 11, 2024 with reinvestment option
Jan 12, 2024
Feb 15, 2024
Jan 11, 2024
Sep 21, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Nov 15, 2023 going ex on Oct 12, 2023 with reinvestment option
Oct 13, 2023
Nov 15, 2023
Oct 12, 2023
查看更多
拆合股
公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
